Founder & CTO, Strainprint

David Berg is the President and CTO at Strainprint Technologies Ltd, a data and analytics company focused on medical cannabis patient interaction. Strainprint's RWE dataset is the largest in the world with over 2.1 million interactions from patients using 7500 lab verified products. Strainprint data solutions provide decision support for patients, doctors, clinics, academic researchers, government regulators, pharmaceutical and biotechnology companies globally. In addition to his work at Strainprint, David works as an advisor to a number of cannabis, data and analytics, biotechnology and therapeutics companies. David holds an MBA from the University of Windsor and a BCom from York University.